Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia.

Saved in:
Bibliographic Details
Title: Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia.
Authors: Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wu C; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rodriguez-Sevilla JJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Hematology, Hospital Clinic, Barcelona, Spain., Wei Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bouligny I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Li Z; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Natu A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Gurney M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel KP; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lasho TL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Finke CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Al-Kali A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Csizmar CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Alkhateeb H; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Mangaonkar AA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Roman-Bravo D; Department of Pathology, Hospital del Mar, Barcelona, Spain., Arenillas L; Department of Pathology, Hospital del Mar, Barcelona, Spain., Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Calvo X; Department of Pathology, Hospital del Mar, Barcelona, Spain., Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Source: Blood cancer discovery [Blood Cancer Discov] 2026 May 05; Vol. 7 (3), pp. 414-430.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2643-3249
DOI:10.1158/2643-3230.BCD-25-0264